[Clofezone, a new potent antirheumatic drug].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002214:Capsules; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005260:Female; D006016:Glycolates / Q000627:therapeutic use*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011111:Polymyalgia Rheumatica / Q000188:drug therapy; D013166:Spondylitis / Q000188:drug therapy; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D013488:Suppositories
D000893:Anti-Inflammatory Agents; D002214:Capsules; D004338:Drug Combinations; D006016:Glycolates; D010919:Placebos; D013488:Suppositories; D010653:Phenylbutazone; D006854:Hydrocortisone
Clofezone, ein neues potentes Antirheumatikum.